D
Hoth Therapeutics, Inc. HOTH
$1.21 -$0.13-9.70% NASDAQ
Recommendation
Prev Close
$1.21
Volume
978,675
Avg Vol (90D)
1,090,023
Market Cap
$15.98M
Dividend & Yield
--
52-Week Range
$0.58 - $3.80
P/E (TTM)
--
EPS (TTM)
-$1.15
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Hoth Therapeutics Regains Nasdaq Compliance - Clears Key Listing Hurdle, Reaffirms Path Toward ...
6/18/2025 - GuruFocus
Hoth Therapeutics Regains Nasdaq Compliance - Clears Key Listing Hurdle, Reaffirms Path Toward ...
6/18/2025 - GuruFocus
Hoth Therapeutics Regains Nasdaq Compliance - Clears Key Listing Hurdle, Reaffirms Path Toward Growth
6/18/2025 - PR Newswire
Hoth Therapeutics (HOTH) Reports Promising Preclinical Outcomes for Cancer Drug HOTH Stock News
6/18/2025 - GuruFocus
Hoth Therapeutics Reports Positive Preclinical Safety Data for Cancer Fighting HT-KIT -- ...
6/18/2025 - GuruFocus
Hoth Therapeutics Reports Positive Preclinical Safety Data for Cancer Fighting HT-KIT -- ...
6/18/2025 - GuruFocus
Hoth Therapeutics reports results from multi-dose study of HT-KIT
6/18/2025 - The Fly
Hoth Therapeutics Reports Positive Preclinical Safety Data for Cancer Fighting HT-KIT -- Dose-Dependent Liver Activity with No Observed Toxicity Supports IND Pathway
6/18/2025 - PR Newswire
Hoth Therapeutics to Attend 2025 BIO International Convention
6/16/2025 - GuruFocus
Hoth Therapeutics to Attend 2025 BIO International Convention HOTH Stock News
6/16/2025 - GuruFocus
Hoth Therapeutics to Attend 2025 BIO International Convention
6/16/2025 - PR Newswire
D. Boral Capital Reiterates "Buy" Rating for Hoth Therapeutics (NASDAQ:HOTH)
6/14/2025 - Ticker Report
Hoth Therapeutics (HOTH) Secures Patent for HT-KIT Platform in Japan HOTH Stock News
6/12/2025 - GuruFocus
Hoth Therapeutics Secures Japanese Patent for Breakthrough HT-KIT Platform Targeting Mast Cell ...
6/12/2025 - GuruFocus
Hoth Therapeutics (HOTH) Receives 'Buy' Rating from D. Boral Capital HOTH Stock News
6/12/2025 - GuruFocus
Hoth Therapeutics Secures Japanese Patent for Breakthrough HT-KIT Platform Targeting Mast Cell ...
6/12/2025 - GuruFocus
Hoth Therapeutics granted Japanese patent for HT-KIT platform
6/12/2025 - TipRanks Financial Blog
Hoth Therapeutics granted Japanese patent for HT-KIT platform
6/12/2025 - The Fly
Hoth Therapeutics Secures Japanese Patent for Breakthrough HT-KIT Platform Targeting Mast Cell Diseases
6/12/2025 - PR Newswire
Hoth Therapeutics Launches Expanded Access Initiative for HT-001, Offering Critical Relief to ...
6/11/2025 - GuruFocus
Hoth Therapeutics Launches Expanded Access Initiative for HT-001, Offering Critical Relief to ...
6/11/2025 - GuruFocus
Hoth Therapeutics announces Expanded Access Program aplication for HT-001
6/11/2025 - The Fly
Hoth Therapeutics Launches Expanded Access Initiative for HT-001, Offering Critical Relief to Cancer Patients Facing Severe Skin Toxicities
6/11/2025 - PR Newswire
Hoth Therapeutics to Spotlight HT-001 in Investor-Focused KOL Event Addressing Breakthrough ...
6/5/2025 - GuruFocus
Hoth Therapeutics to Spotlight HT-001 in Investor-Focused KOL Event Addressing Breakthrough ...
6/5/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
-$9.64M
Net Income (TTM)
-$9.62M
Balance Sheet
Total Assets (Q)
$12.36M
Total Debt (Q)
$28.90K
Total Liabilities (Q)
$815.30K
Book Value Per Share (Q)
$0.8762
Cash Flow
Cash from Operations (TTM)
-$8.04M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$11.81M
Net Change in Cash (TTM)
$3.75M
Filings
Filing Date
Monday, May 12, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Loading...
Beta
1.19
7-Day Total Return
-8.33%
30-Day Total Return
24.87%
60-Day Total Return
18.63%
90-Day Total Return
18.63%
Year to Date Total Return
57.12%
1-Year Total Return
30.95%
2-Year Total Return
-59.40%
3-Year Total Return
-87.77%
5-Year Total Return
-98.15%
52-week Low
Aug 08, 2024 - $0.58
52-week High
Jan 07, 2025 - $3.80
Valuation
Market Cap
$15.98M - Nano Cap
Enterprise Value
$4.69M
Price/Sales (TTM)
--
Price/Book (Q)
1.38
Dividends and Shares
Shares Outstanding
12.73M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
hoththerapeutics.com
Phone Number
(646) 756-2997
Address
1177 Avenue of the Americas
Suite 5066 - 5th Floor
New York, NY 10036
Country
United States
Year Founded
2017
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It develops HT-001, a topical formulation in Phase II clinical trial... more
NASDAQ 06/20/2025 4:00PM Eastern Quotes delayed